Maternal plasma fibronectin and advanced oxidative protein products for the prediction of preeclampsia in high risk pregnancies: A prospective cohort study

Fetal Diagnosis and Therapy

Volumn 26, Issue 4, 2009, Pages 189-194

  Dane, Cem ^a   Buyukasik, Hasan ^a   Dane, Banu ^a   Yayla, Murat ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Advanced oxidative protein products; Fibronectin; High risk pregnancy; Prediction of preeclampsia

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; FIBRONECTIN;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL PLASMA; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SECOND TRIMESTER PREGNANCY;

ADULT; BLOOD PROTEINS; FEMALE; FIBRONECTINS; HUMANS; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; SENSITIVITY AND SPECIFICITY;

EID: 73649107263     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000259317     Document Type: Article

References (30)

1. Leeflang MM, Cnossen JS, van der Post JA, Mol BW, Khan KS, ter Riet G: Accuracy of fibronectin tests for the prediction of pre-eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2007; 133: 12-19.
2. Gredmark T, Bergman B, Hellström L: Total fibronectin in maternal plasma as a predictor for preeclampsia. Gynecol Obstet Invest 1999; 47: 89-94.
3. Dreyfus M, Baldauf J, Ritter J, Van Cauwenberg J, Hardy A, Foidart J: The prediction of preeclampsia: reassessment of clinical value of increased plasma levels of fibronectin. Eur J Obstet Gynecol Reprod Biol 1998; 78: 25-28.
4. Palma-Dias RS, Fonseca MM, Brietzke E, Fritsch A, Schlatter D, Maurmann CB, Stein NR, Magalhães JA: Screening for placental insufficiency by transvaginal uterine artery Doppler at 22-24 weeks of gestation. Fetal Diagn Ther 2008; 24: 462-469.
5. Rodrigo R, Parra M, Bosco C, Fernández V, Barja P, Guajardo J, Messina R: Pathophysiological basis for the prophylaxis of preeclampsia through early supplementation with antioxidant vitamins. Pharmacol Ther 2005; 107: 177-197.
6. Zeeman GG, Dekker GA, van Geijn HP, Kraayenbrink AA: Endothelial function in normal and preeclamptic pregnancy: a hypothesis. Eur J Obstet Gynecol Reprod Biol 1992; 43: 113-122.
7. Madazli R, Budak E, Calay Z, Aksu MF: Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia. BJOG 2000; 107: 514-518.
8. Baumann MU, Bersinger NA, Surbek DV: Plasma markers for predicting pre-eclampsia. Mol Aspects Med 2007; 28: 227-244.
9. Mohaupt M: Molecular aspects of preeclampsia: oxidative stress impairs endothelial function and may play an important role in the pathogenesis of preeclampsia. Mol Aspects Med 2007; 28: 169-191.
10. Llurba E, Gratacós E, Martín-Gallán P, Cabero L, Dominguez C: A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 2004; 37: 557-570.
11. Gupta S, Agarwal A, Sharma RK: The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 2005; 60: 807-816.
12. Fialová L, Kalousová M, Soukupová J, Malbohan I, Madar J, Frisová V, Stípek S, Zima T: Markers of inflammation in preeclampsia. Prague Med Rep 2004; 105: 301-310.
13. Witko-Sarsat V, Gausson V, Nguyen AT, Touam M, Drüeke T, Santangelo F, Descamps-Latscha B: AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 2003; 64: 82-91.
14. Farag K, Hassan I, Ledger W: Prediction of preeclampsia: can it be achieved? Obstet Gynecol Surv 2004; 59: 464-482.
15. Madazli R, Kuseyrioglu B, Uzun H, Uludag S, Ocak V: Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry. Int J Gynaecol Obstet 2005; 89: 251-257.
16. Bayhan G, Atamer Y, Atamer A, Yokus B, Baylan Y: Significance of changes in lipid peroxides and antioxidant enzyme activities in pregnant women with preeclampsia and eclampsia. Clin Exp Obstet Gynecol 2000; 27: 142-146.
17. Bowen RS, Moodley J, Dutton MF, Theron AJ: Oxidative stress in pre-eclampsia. Acta Obstet Gynecol Scand 2001; 80: 719-725.
18. Chavarria M, Lara-Gonzalez L, Gonzalez-Gleason A, Sojo I, Reyes A: Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: a longitudinal study for early prediction of preeclampsia. Am J Obstet Gynecol 2002; 187: 595-601.
19. Paternoster DM, Stella A, Mussap M, Plebani M, Gambaro G, Grella PV: Predictive markers of pre-eclampsia in hypertensive disorders of pregnancy. Int J Gynaecol Obstet 1999; 66: 237-243.
20. Pignot S, Busine A: Fibronectin: an early marker of pre-eclampsia. J Gynecol Obstet Biol Reprod (Paris) 1989; 18: 867-870.
21. Lazarchick J, Stubbs TM, Romein L, Van Dorsten JP, Loadholt CB: Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol 1986; 154: 1050-1052.
22. Paarlberg KM, de Jong CL, van Geijn HP, van Kamp GJ, Heinen AG, Dekker GA: Total plasma fibronectin as a marker of pregnancy-induced hypertensive disorders: a longitudinal study. Obstet Gynecol 1998; 91: 383-388.
23. Aydin T, Varol FG, Sayin NC: Third trimester maternal plasma total fibronectin levels in pregnancy induced hypertension: results of a tertiary center. Clin Appl Thromb Hemost 2006; 12: 33-39.
24. Chavarria ME, Gonzalez LL, Gleason AG, Sojo I, Reyes A: Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: a longitudinal study for early prediction of preeclampsia. Am J Obstet Gynecol 2002; 187: 585-601.
25. Powers RW, Catov JM, Bodnar LM, Gallaher MJ, Lain KY, Roberts JM: Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome. Reprod Sci 2008; 15: 374-381.
26. Serdar Z, Gür E, Colakoethullary M, Develioethlu O, Sarandöl E: Lipid and protein oxidation and antioxidant function in women with mild and severe preeclampsia. Arch Gynecol Obstet 2003; 268: 19-25.
27. Sharma JB, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal S: Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 2006; 94: 23-27.
28. Coskun C, Kural A, Döventas Y, Koldas M, Ozturk H, Inal BB, Gümüs A: Hemodialysis and protein oxidation products. Ann NY Acad Sci 2007; 1100: 404-408.
29. Noyan T, Güler A, Sekeroǧlu MR, Kamaci M: Plasma advanced oxidation protein products, myeloperoxidase and ascorbic acid in pre-eclampsia and eclampsia. Aust NZ J Obstet Gynaecol 2006; 46: 486-491.
30. Perkins AV: Endogenous anti-oxidants in pregnancy and preeclampsia. Aust NZ J Obstet Gynaecol 2006; 46: 77-83.